TOVX Theriva Corp Company Short-Term Debt

Theriva Biologics - graphic logo of issuer TOVX

The Theriva Biologics, Inc. (TOVX) price chart demonstrates financial metrics where the debt load stands at 0.00. Stable management adheres to disciplined spending, confidently overseeing research operations. The business relies on the creation of viruses that disrupt the protective layer of pancreatic tumors to enable drug access. High profitability is driven by a flexible platform that allows for the low-cost production of innovative treatments on a global scale.

TOVX therivabio.com Short-Term Debt (04/28/2023 - 11/01/2026)

Analytical breakdowns and data insights for company Theriva Corp (TOVX)

- current quotes and average value forecast:
Price Chart Theriva Biologics|TOVX - Average Forecast Price
- market capitalization data:
Market Value Theriva Biologics, Inc.|TOVX - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Theriva Biologics|TOVX - Total Stockholders' Equity|Market Capitalization to Book Value Ratio therivabio.com|TOVX - Company Balance Sheet Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Theriva Biologics, Inc.|TOVX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Theriva Biologics, Inc.|TOVX - Aggregate Debt Obligations|Debts to Book Capitalization Theriva Biologics, Inc.|TOVX - Long-Term Debt Volume|Company Short-Term Debt Theriva Biologics|Quick Liquidity therivabio.com
- earnings and multiples data:
TOVX - Net Income
General company analysis:Theriva Biologics (TOVX)
Flagship merchandise of therivabio.com

For Theriva Biologics, Inc. (TOVX), which lacks revenue and depends on external financing, the history of short-term debt changes serves as an indicator of critical liquidity. This metric aggregates all obligations with a maturity of up to one year, allowing for an assessment of default risk in the absence of new grants and determining capital stability amid high uncertainty in clinical developments.

Competitors of Theriva Biologics, Inc.

IBRX - Company Short-Term Debt|Short-Term Debt Immunocore Holdings|Janux Pharma (JANX) - Company Short-Term Debt|RCUS (Arcus Corp) - Company Short-Term Debt|Company Short-Term Debt Zymeworks Inc.|Short-Term Debt tangotx.com TNGX|Company Short-Term Debts IOVA|Immatics NV (IMTX) - Short-Term Indebtedness|Xencor Corp - Company Current Liabilities|Compass Therapeutics Corp (CMPX) - Short-Term Debt|REPL: Company Current Liabilities|Company Short-Term Loans and Borrowings LYEL (lyell.com)|IPHA: Company Short-Term Debts|PYXS - Short-Term Debt Volume|Company Short-Term Debt Compugen Ltd|Company Current Liabilities IO Biotech Inc. (IOBT)|Company Short-Term Debt Sutro Biopharma, Inc. (STRO)|Company Current Liabilities minktherapeutics.com INKT|Werewolf Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts Immix Biopharma Inc. IMMX|ALXO - Company Short-Term Debt|CUE (Cue Biopharma Inc.) - Company Short-Term Indebtedness|pdsbiotech.com (PDSB) - Company Short-Term Debt|Short-Term Debt Sonnet BioTherapeutics Holdings (SONN)|Company Current Liabilities MAIA|LIMN - Short-Term Indebtedness|Company Current Liabilities LVTX (LAVA Therapeutics N.V.)|Amount of Current Liabilities NXTC|Company Short-Term Debts LPTX (Leap Therapeutics)|Company Short-Term Loans and Borrowings INTS|Sensei Bio - Company Short-Term Debts|Short-Term Debt Gritstone bio, Inc.|Kineta Bio (KA) - Company Short-Term Debt|NexImmune Corporation - Company Short-Term Loans and Borrowings|TSBX (Turnstone Biologics Corp) - Company Short-Term Debts|Company Short-Term Debts vaccinex.com|Company Short-Term Debt Harpoon Therapeutics, Inc. (HARP)